Absence of IL-6 receptor expression in fresh childhood Burkitt's lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro

British Journal of Haematology

Volumn 97, Issue 2, 1997, Pages 400-408

  Tomeczkowski, Jörg ^a   Stadt, Udo Zur ^a   Reiter, Alfred ^a   Welte, Karl ^a   Sykora, Karl Walter ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Burkitt's lymphoma; cellular proliferation; cytokines; Epstein Barr virus; interleukin 6 receptor

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6 RECEPTOR;

ARTICLE; BURKITT LYMPHOMA; CHILDHOOD CANCER; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 8244248452     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.232666.x     Document Type: Article

References (39)

1. Andreeff, M. & Welte, K. (1989) Hematopoietic colony stimulating factors. Seminars in Oncology, 16, 211-229.
2. Appelbaum, F.R. (1993) The use of colony stimulating factors in marrow transplantation. Cancer, 72, 3387-3392.
3. Baumann, M., Baumann, H. & Fey, G.H. (1990) Molecular cloning, characterization and functional expression of the rat liver interleukin 6 receptor. Journal of Biological Chemistry, 265, 19853-19862.
4. Brenner, M.K. (1995) The use of cytokines to improve gene transfer to human hematopoietic stem cells. Cytokines and Molecular Therapy, 1, 3-9.
5. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood, 81, 2579-2584.
6. Calender, A., Billaud, M., Aubry, J.-P., Banchereau, J., Vuillaume, M. & Lenoir, G.M. (1987) Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America, 84, 8060-8064.
7. Duggan, D.B., Santarelli, M.T., Zamkoff, K., Lichtman, S., Ellerton, J., Cooper, R., Poiesz, B., Anderson, J.R., Bloomfield, C.D., Peterson, B.A. & Gottlieb, A.J. (1992) A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma: a study of the Cancer and Leukemia Group B. Journal of Immunotherapy, 12, 115-122.
8. Emilie, D., Leger Ravet, M.B., Devergne, O., Raphael, M., Peuchmaur, M., Coumbaras, J., Crevon, M.C. & Galanaud, P. (1993) Intratumoral production of IL-6 in B cell chronic lymphocytic leukemia and B lymphomas. Leukemia and Lymphoma, 11, 411-417.
9. Falk, M.H., Trauth, B.C., Debatin, K.-M., Klas, C., Gregory, C.D., Rickinson, A.B., Calender, A., Lenoir, G.M., Ellwart, J.W., Krammer, P.H. & Bornkamm, G.W. (1992) Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood, 79, 3300-3306.
10. Freeman, G.J., Freedman, A.S., Rabinowe, S.N., Segil, J.M., Horowitz, J., Rosen, K., Whitman, J.F. & Nadler, L.M. (1989) Interleukin 6 gene expression in normal and neoplastic B cells. Journal of Clinical Investigation, 83, 1512-1518.
11. + cells into the myeloid lineage. Blood, 80, 1405-1412.
12. Helle, M., Brakenhoff, J.P., De Groot, K.P., & Aarden, L.A. (1988) Interleukin 6 is involved in interleukin 1-induced activities. European Journal of Immunology, 18, 957-959.
13. Henschler, R., Brugger, W., Kanz, L. & Mertelsmann, R. (1994) Haematopoietic growth factors in clinical medicine. European Journal of Cancer, 30A, 118-119.
14. Ho, A.D., Haas, R., Wulf, G., Knauf, W., Ehrhardt, R., Heilig, B., Korbling, M., Schulz, G. & Hunstein, W. (1990) Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma. Blood, 75, 203-212.
15. Hsu, S.-M., Waldron, J.W., Hsu, P.-L. & Hough, A.J. (1993) Cytokines in malignant lymphomas: review and prospective evaluation. Human Pathology, 24, 1040-1057.
16. Janssen, O., Gillis, S. & Kabelitz, D. (1990) In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti IgM responsiveness in a human leukemic B cell clone. European Journal of Immunology, 20, 7-14.
17. Lenoir, G.M., Vuillaume, M. & Bonnardel, C. (1985) The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. IARC SCI Publication, pp. 309-318.
18. Longnecker, R. (1994) Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2. Leukemia, 8, (Suppl. 1), S46-S50.
19. Matsuo, Y., Motoori, T., Irie, K., Natori, H., Hayashi, A., Mizote, H., Sagawa, K. & Yokoyama, M.M. (1985) [Establishment and characterization of an interleukin-2 receptor bearing a Burkitt's lymphoma cell line (ABL-2)]. Nippon Ketsueki Gakkai Zasshi, 48, 1187-1197.
20. Miller, C.L., Burkhardt, A.L., Lee, J.H., Stealey, B., Longnecker, R., Bolen, J.B. & Kieff, E. (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity, 2, 155-166.
21. Miller, C.L., Lee, J.H., Kieff, E. & Longnecker, R. (1994) An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences of the United States of America, 91, 772-776.
22. Onozaki, K., Akiyama, Y., Okano, A., Hirano, T., Kishimoto, T., Hashimoto, T., Yoshizawa, K. & Taniyama, T. (1989) Synergistic regulatory effects of interleukin 6 and interleukin 1 on the growth and differentiation of human and mouse myeloid leukemic cell lines. Cancer Research, 49, 3602-3607.
23. Pang, Y., Norihisa, Y., Benjamin, D., Kantor, R.R. & Young, H.A. (1992) Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood, 80, 724-732.
24. Pettengell, R., Testa, N.G., Swindell, R., Crowther, D. & Dexter, T.M. (1993) Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239-2248.
25. Philip, I., Philip, T., Favrot, M., Vuillaume, M., Fontaniere, B. & Journal of the National Cancer Institute, 73, 835-840.
26. Rooney, C.M., Gregory, C.D., Rowe, M., Finerty, S., Edwards, C., Rupani, H. & Rickinson, A.B. (1986) Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. Journal of the National Cancer Institute, 77, 681-687.
27. Rowe, D., Heston, L., Metlay, J. & Miller, G. (1985) Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. Proceedings of the National Academy of Sciences of the United States of America, 82, 7429-7433.
28. Rowe, M., Rooney, C.M., Edwards, C.F., Lenoir, G.M. & Rickinson, A.B. (1985) Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma. International Journal of Cancer, 37, 367-373.
29. Rowe, M., Rowe, D.T., Gregory, C.D., Young, L.S., Farrell, P.J., Rupani, H. & Rickinson, A.B. (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO Journal, 6, 2743-2751.
30. Smith, S.D., Rubin, C.M., Horvath, A. & Nachman, J. (1990) Non-Hodgkin's lymphoma in children. Seminars in Oncology, 17, 113-119.
31. Steel, C.M. & Hutchins, D. (1989) Soluble factors and cell-surface molecules involved in human B lymphocyte activation, growth and differentiation. Biochimica et Biophysica Acta, 989, 133-151.
32. Taga, T., Kawanishi, Y., Hardy, R.R., Hirano, T. & Kishimoto, T. (1987) Receptors for B cell stimulatory factor 2: quantitation, specificity, distribution, and regulation of their expression. Journal of Experimental Medicine, 166, 967-981.
33. Tolan, D.R., Amsden, A.B., Putney, S.D., Urdea, M.S. & Penhoet, E.E. (1984) The complete nucleotide sequence for rabbit muscle aldolase A messenger RNA. Journal of Biological Chemistry, 259, 1127-1131.
34. Tomeczkowski, J., Beilken, A., Frick, D., Wieland, B., König, A., Halk, M.H., Reiter, A., Welte, K. & Sykora, K.-W. (1995a) Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells. Blood, 86, 1469-1480.
35. Tomeczkowski, J., Yakisan, E., Wieland, B., Reiter, A., Weite, K. & Sykora, K.-W. (1995b) Absence of G-CSF receptors and absent response to G-CSF in childhood Burkitt's lymphoma and B-ALL cells. British Journal of Haematology, 89, 771-779.
36. Torcia, M., Aldinucci, D., Carossino, A.M., Imreh, F. & Cozzolino, F. (1989) Biologic and clinical significance of cytokine production in B-cell malignancies. European Journal of Haematology, 43, (Suppl.), 35-42.
37. Wagner, D.K., Kiwanuka, J., Edwards, B.K., Rubin, L.A., Nelson, D.I., & Magrath, L.T. (1987) Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. Journal of Clinical Oncology, 5, 1262-1274.
38. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T. & Kishimoto, T. (1988) Cloning and expression of the human interleukin-6 (BSF-2/1FNβ 2) receptor. Science, 241, 825-828.
39. Yee, C., Biondi, A., Wang, X.H., Iscove, N.N., Sousa, J.D., Aarden, L.A., Wong, G.G., Clark, S.C., Messner, H.A. & Minden, M.D. (1989) A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood, 74, 798-804.